Approximately 1–4% of patients with multiple CALM who meet the 1988 clinical diagnostic criteria for NF1 have Legius syndrome since they harbour SPRED1 pathogenic variants (Brems et al. 2012). Here, SPRED1 is linked to neurofibromatosis type 1.